Regulatory Updates
🇪🇺 EMA Page 8EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 85–96 of 171 articles
Bio/Pharma Outlook 2026: Regulatory Updates and Implications
Global Biosimilar Market Analysis: Trends and Challenges
Actinogen's EMA Scientific Advice: A Positive Step for Alzheimer's Program
Innovent Biologics Shares Surge 10% Following Pfizer Deal
Arrowhead Pharmaceuticals Unveils Positive Clinical Data at EAS Congress
Innovent Biologics and Pfizer's $10.5 Billion Cancer Drug Deal
LENZ Therapeutics Submits VIZZ® Application to EMA for Presbyopia
From Promise to Proof: The Shakeup in Today’s Biosimilar Market
EMA Endorses Novo Nordisk's Wegovy for Weight Loss
Navigating the 2026 Cell Therapy Regulatory Landscape
ESMO 2025 Preview: Astra and Daiichi vs. Gilead
Imfinzi Receives FDA Approval for Bladder Cancer Treatment